CompuGROUP and Knappschaft Bahn See Launch Pilot Programme

CompuGROUP Holding AGCompuGROUP Holding AG, the e-health service company with the broadest reach among service providers world-wide, is now supporting the integrated treatment of patients suffering from Type 2 diabetes mellitus through its subsidiary GIV. Client Knappschaft Bahn See expects the programme to provide more effective patient care and reduce costs significantly.

In the fourth quarter of 2008, Knappschaft Bahn See and the CompuGROUP subsidiary Gesellschaft für angewandte integrierte Versorgungsformen (GiV) mbH in the Saarland launched an innovative, fully practicable, integrated treatment programme: prosper Versorgungsmanagement Diabetes. The goal is to optimize treatment in order to improve the health of manifest diabetics and risk patients on a sustained basis. Apart from this top-priority medical goal, the programme is also expected to reduce the consequential costs of diabetes, which account for up to 80% of total treatment costs for these patients.

The foundation of the prosper programme is a health-care network established by Knappschaft and composed of family doctors, specialists and hospitals in a given region. The prosper Saar health-care network consists of over 300 physicians, of whom 50 are now participating in the interdisciplinary, cross-sector prosper Versorgungsmanagement Diabetes programme.

The heart of prosper Versorgungsmanagement Diabetes consists of a central, indication-based case file and an innovative diagnostic and treatment path derived from data contained in the file - both elements developed by CompuGROUP. All relevant information is entered in the file by participating physicians. It includes comprehensive treatment data on Type 2 diabetes patients as well as information about identified risk patients. On the basis of this medical data, the treatment path provides specific guideline-oriented recommendations for treatment teams at the moment a medical decision needs to be made. The diabetes mellitus path was developed by the medical team at CompuGROUP in consultation with the renowned expert Prof. Dr. Werner Scherbaum of Düsseldorf. "Our goal is to offer doctors only those 'bits of information' they really need - at precisely the right moment and integrated directly into the physician's workflow", explains Frank Ladendorf, Managing Director of GiV.

Prof. Dr. med. Werner Scherbaum, Director of the Endocrinology, Diabetology and Rheumatology Clinic at the Düsseldorf University Hospital, goes one step further: "The prosper Versorgungsmanagement Diabetes programme responds to the repeatedly expressed appeal for a practicable diagnostic and treatment system controlled primarily by family physicians. Specialist treatment can be integrated without difficulty. Making the best use of existing resources, developing them through innovation and thus doing more for patients and their health - these are the primary objectives of prosper Versorgungsmanagement Diabetes."

Frank Ladendorf emphasizes the potential savings for health insurers: "We are already seeing evidence that prosper Versorgungsmanagement Diabetes enhances the efficiency of patient treatment while ensuring quality and cost-effectiveness on a sustainable basis. Our software makes a valuable contribution in that context. I'm sure", Ladendorf adds, "that other health insurers will soon be using intelligent-software-aided systems of this kind to increase efficiency as well."

"We hope to find out", says Hans Adolf Müller, Health Management Director at Knappschaft Bahn See, "whether this innovative decision-support system will enable us to help our policyholders more effectively and to provide more systematic support to treating physicians and their teams." CompuGROUP has proven to be a strong partner. As the market leader, CompuGROUP has broad, central access to practising physicians thanks to the widespread use of its physicians' information system.

According to Frank Ladendorf, "Treatment management systems of this kind work only if they are accepted by physicians. We gain that acceptance by integrating the system into existing workflows and by ensuring complete transparency - with respect to prescriptions, for example." The pilot project is scheduled to run until the end of 2009, after which it will be evaluated for the purpose of assessing the practicability and the added benefits of this form of integrated treatment. If the positive results shown thus far are confirmed, the programme will be launched on a broad basis and expanded to include other guideline-oriented patient paths for other widespread diseases in 2010.

Related news articles:

About CompuGROUP Holding AG
CompuGROUP is one of the leading e-health companies worldwide. Its software products, designed to support all medical and organizational activities in doctors' offices and hospitals, its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. The services of CompuGROUP are based on its unique customer base of around 326,000 doctors, dentists, hospitals and networks as well as other service providers. CompuGROUP is the e-health company with the biggest coverage among e-health service providers worldwide. The company operates in 14 European countries, Malaysia, Saudi Arabia, South Africa and in the USA and currently employs around 2,700 people.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...